Michael Baker

Senior Director, Viral Gene Therapy, FUJIFILM Diosynth Biotechnologies

Michael is responsible for overseeing FUJIFILM Diosynth Biotechnologies’ (FDB) Viral Gene Therapy operations in the UK. Prior to this he spent 4 years at FDB’s College Station location in Texas USA where he was Head of Process Development, and was responsible for leading a rapidly expanding process development team. He has previously served in a number of technical roles at FDB’s sites in Texas and the UK and before joining FDB, worked for MSD Biologics and Avecia Biotechnology. Michael gained a BSc in Medical Microbiology and Immunology and an MPhil in Developmental Biology from Newcastle University.

Stevenage Bioscience Catalyst

30 November 2023